Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 91

1.

Use of select medications prior to duloxetine initiation among commercially-insured patients.

Bernauer M, Wu N, Chen SY, Peng X, Boulanger L, Zhao Y.

J Pain Res. 2012;5:271-8. doi: 10.2147/JPR.S33438. Epub 2012 Aug 14.

2.

Factors associated with pain medication selection among patients diagnosed with diabetic peripheral neuropathic pain: a retrospective study.

Chen S, Wu N, Boulanger L, Fraser K, Zhao Z, Zhao Y.

J Med Econ. 2011;14(4):411-20. doi: 10.3111/13696998.2011.585676. Epub 2011 May 26.

PMID:
21615268
3.

Predictors of pain medication selection among patients diagnosed with fibromyalgia.

Boulanger L, Wu N, Chen SY, Nagar S, Fraser K, Bernauer MJ, Zhao Z, Zhao Y.

Pain Pract. 2012 Apr;12(4):266-75. doi: 10.1111/j.1533-2500.2011.00497.x. Epub 2011 Sep 8.

PMID:
21899718
4.

Real-world comparison of health care utilization between duloxetine and pregabalin initiators with fibromyalgia.

Peng X, Sun P, Novick D, Andrews J, Sun S.

J Pain Res. 2014 Jan 9;7:37-46. doi: 10.2147/JPR.S51636. eCollection 2014.

5.

Medication adherence and healthcare costs among patients with diabetic peripheral neuropathic pain initiating duloxetine versus pregabalin.

Zhao Y, Sun P, Watson P.

Curr Med Res Opin. 2011 Apr;27(4):785-92. doi: 10.1185/03007995.2011.554807. Epub 2011 Feb 8.

PMID:
21303196
6.

Comparison of medication adherence and healthcare costs between duloxetine and pregabalin initiators among patients with fibromyalgia.

Zhao Y, Sun P, Watson P, Mitchell B, Swindle R.

Pain Pract. 2011 May-Jun;11(3):204-16. doi: 10.1111/j.1533-2500.2010.00412.x. Epub 2010 Aug 27.

PMID:
20807351
7.

Real-world treatment patterns and opioid use in chronic low back pain patients initiating duloxetine versus standard of care.

Andrews JS, Wu N, Chen SY, Yu X, Peng X, Novick D.

J Pain Res. 2013 Nov 26;6:825-35. doi: 10.2147/JPR.S50323. eCollection 2013.

8.

Duloxetine treatment adherence across mental health and chronic pain conditions.

Able SL, Cui Z, Shen W.

Clinicoecon Outcomes Res. 2014 Feb 11;6:75-81. doi: 10.2147/CEOR.S52950. eCollection 2014.

9.
10.

Utilization of duloxetine and celecoxib in osteoarthritis patients.

Peng X, Wu N, Chen SY, Yu X, Andrews JS, Novick D.

Curr Med Res Opin. 2013 Sep;29(9):1161-9. doi: 10.1185/03007995.2013.816275. Epub 2013 Jul 10.

PMID:
23777314
11.

Treatment adherence and persistence with duloxetine, venlafaxine XR, and escitalopram among patients with major depressive disorder and chronic pain-related diseases.

Wang J, Liu X, Mullins CD.

Curr Med Res Opin. 2011 Jul;27(7):1303-13. doi: 10.1185/03007995.2011.576663. Epub 2011 May 12.

PMID:
21561393
12.

Patterns of therapy switching, augmentation, and discontinuation after initiation of treatment with select medications in patients with osteoarthritis.

Gore M, Sadosky A, Leslie D, Tai KS, Seleznick M.

Clin Ther. 2011 Dec;33(12):1914-31. doi: 10.1016/j.clinthera.2011.10.019. Epub 2011 Nov 14.

PMID:
22088416
13.

Predictors of duloxetine versus other treatments among veterans with diabetic peripheral neuropathic pain: a retrospective study.

Zhao Y, Liu J, Zhao Y, Thethi T, Fonseca V, Shi L.

Pain Pract. 2012 Jun;12(5):366-73. doi: 10.1111/j.1533-2500.2011.00494.x. Epub 2011 Sep 27.

PMID:
21951753
14.

Factors associated with duloxetine treatment among patients with major depressive disorder in Veterans Health Administration: a retrospective study.

Shi L, Liu J, Campbell C, Zhao Y.

Curr Med Res Opin. 2010 Dec;26(12):2715-21. doi: 10.1185/03007995.2010.530140. Epub 2010 Oct 25.

PMID:
20973616
15.

A review of duloxetine 60 mg once-daily dosing for the management of diabetic peripheral neuropathic pain, fibromyalgia, and chronic musculoskeletal pain due to chronic osteoarthritis pain and low back pain.

Pergolizzi JV Jr, Raffa RB, Taylor R Jr, Rodriguez G, Nalamachu S, Langley P.

Pain Pract. 2013 Mar;13(3):239-52. doi: 10.1111/j.1533-2500.2012.00578.x. Epub 2012 Jun 21. Review.

PMID:
22716295
16.

Medication adherence and healthcare costs among fibromyalgia patients treated with duloxetine.

Zhao Y, Chen SY, Wu N, Fraser KA, Boulanger L.

Pain Pract. 2011 Jul-Aug;11(4):381-91. doi: 10.1111/j.1533-2500.2010.00431.x. Epub 2010 Dec 29.

PMID:
21199311
18.
19.

Suboptimal Treatment of Diabetic Peripheral Neuropathic Pain in the United States.

Yang M, Qian C, Liu Y.

Pain Med. 2015 Nov;16(11):2075-83. doi: 10.1111/pme.12845. Epub 2015 Jun 27.

PMID:
26118704
20.

Direct medical costs and medication compliance among fibromyalgia patients: duloxetine initiators vs. pregabalin initiators.

Sun P, Peng X, Sun S, Novick D, Faries DE, Andrews JS, Wohlreich MM, Wu A.

Pain Pract. 2014 Jan;14(1):22-31. doi: 10.1111/papr.12044. Epub 2013 Mar 14.

PMID:
23489659

Supplemental Content

Support Center